ACCeptation and Qualitative Evaluation of Phone-delivered Intervention

NCT ID: NCT02949453

Last Updated: 2019-04-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

19 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-03-03

Study Completion Date

2019-04-04

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Background: Previous suicide attempt is known to be a strong risk factor for repetition and repetition is common within the first year after an episode of deliberate self-harm (DSH). There has been growing interest in brief interventions for this population that are focused on maintaining long-term contact and/or offering re-engagement with services when needed. Despite telephone-delivered interventions have shown promising results in suicide reattempt prevention, subjective impact of such brief contact interventions and effectiveness mechanisms have never been evaluated.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Semi-structured in-depth interviews with 20 patients previously receiving a telephone-delivered intervention from our team. Six weeks and 3 months after a DSH, people included in telephone-delivered process will be interviewed by a social science researcher. Qualitative analysis using thematic analysis will be independently performed by two researchers.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Suicide

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

patients after suicidal episode

Patients receiving a telephone-delivered intervention after deliberate self-harm (DSH)

Group Type EXPERIMENTAL

Semi-directed interview performed by a social sciences researcher

Intervention Type BEHAVIORAL

Two semi-directed interviews performed by social sciences researcher:

* first interview performed 6 weeks after the suicide attempt, in an suicide prevention unit, duration 1 to 1.5 hour
* second interview performed 3 month after the suicide attempt, in a suicide prevention unit, duration 1 to 1.5 hour

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Semi-directed interview performed by a social sciences researcher

Two semi-directed interviews performed by social sciences researcher:

* first interview performed 6 weeks after the suicide attempt, in an suicide prevention unit, duration 1 to 1.5 hour
* second interview performed 3 month after the suicide attempt, in a suicide prevention unit, duration 1 to 1.5 hour

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Deliberate self-harm in the previous week,
* 18 years old and older,
* outpatient care orientation after discharge from emergency department

Exclusion Criteria

* Difficulties in french language,
* mental retardation
Minimum Eligible Age

18 Years

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hospices Civils de Lyon

OTHER

Sponsor Role collaborator

Hôpital le Vinatier

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

TERRA JEAN-LOUIS, PUPH

Role: PRINCIPAL_INVESTIGATOR

Centre Hospitalier le Vinatier

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hopital Vinatier

Bron, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2016-A00919-42

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.